Flower Mound, Texas-based BioTech startup ProTom International has received FDA 510(k) Clearance for its Radiance 330 ® Proton Therapy System. This clearance, officially making Radiance 330 ® commercially available, was instrumental in ProTom being awarded two new system orders — one at Massachusetts General Hospital (MGH), Boston and another at Atlantic Health System, New Jersey.